HomeASMB • NASDAQ
add
Assembly Biosciences Inc
Previous close
$28.23
Day range
$28.45 - $29.50
Year range
$7.76 - $39.71
Market cap
452.09M USD
Avg Volume
94.66K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 42.47M | 477.26% |
Operating expense | 5.42M | 17.60% |
Net income | 22.09M | 313.74% |
Net profit margin | 52.01 | 137.02% |
Earnings per share | 2.48 | 257.96% |
EBITDA | 19.83M | 272.44% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 248.11M | 121.37% |
Total assets | 257.59M | 116.16% |
Total liabilities | 50.84M | -40.75% |
Total equity | 206.75M | — |
Shares outstanding | 15.86M | — |
Price to book | 2.16 | — |
Return on assets | 19.89% | — |
Return on capital | 25.07% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 22.09M | 313.74% |
Cash from operations | 14.24M | 3,598.03% |
Cash from investing | 21.22M | 416.95% |
Cash from financing | 456.00K | -97.32% |
Net change in cash | 35.92M | 263.08% |
Free cash flow | 7.03M | 1,475.45% |
About
Founded
2005
Headquarters
Website
Employees
73
